India New Issue-Eris Lifesciences accepts bids for bond issue, bankers say
MUMBAI, June 7 (Reuters) - India's Eris Lifesciences ERIS.NS has accepted bids worth
12.50 billion rupees ($149.78 million) through the sale of separately transferable redeemable
principal part (STRPP) bonds maturing in three years, three bankers said on Friday.
It will pay a 8.73% coupon on the bond issue and had invited bids on Thursday, they said.
Here is the list of deals reported so far on June 7:
Issuer Tenure Coupon (in %) Issue size (in Bidding Rating
bln rupees)* date
Eris 3 years 8.73 12.50 June 6 AA- (India
Lifesciences Ratings)
3 years and 8.3333 4.75 June 6 AAA (Crisil,
HDB Financial 2 months Careedge)
Services
5 years 8.65 6.50 June 6 AA (Crisil)
TVS Holdings
*Size includes base plus greenshoe for some issues
($1 = 83.4575 Indian rupees)
(Reporting by Dharamraj Dhutia and Bhakti Tambe; Editing by Sohini Goswami)
((Dharamraj.dhutia@tr.com))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees